Piotr Wnuk, Author at - Page 8 of 14

News/ News/ Sales and Marketing/ Top stories

Bayer hits back at Netflix medical device documentary

Piotr Wnuk Bayer, contraception, Essure, fda, medical devices, Netflix, patient safety, The Bleeding Edge 0 Comment

Bayer has issued a robust defence of Essure after the birth control implant was featured in The Bleeding

Bayer hits back at Netflix medical device documentary

https://pharmaphorum.com/news/bayer-netflix-essure-safety/

News/ News/ Oncology

EU regulators reject new use for Opdivo, as Keytruda edges ahead

Piotr Wnuk Bristol-Myers Squibb, cancer, immunotherapy, Merck & Co 0 Comment

Keytruda begins to win battle of the immunotherapies

EU regulators reject new use for Opdivo, as Keytruda edges ahead

https://pharmaphorum.com/news/eu-regulators-reject-new-use-for-opdivo-as-keytruda-edges-ahead/

News/ News/ R&D

Merck & Co’s Keytruda shows potential in head and neck cancer use

Piotr Wnuk Erbitux, Keytruda, Merck&Co, Opdivo 0 Comment

Merck & Co might be able to find another use for its immunotherapy Keytruda in first line head

Merck & Co’s Keytruda shows potential in head and neck cancer use

https://pharmaphorum.com/news/keytruda-shows-promise-first-line-skin-cancer-treatment/

GlaxoSmithKline/ News/ News/ R&D/ Top pharmaceutical companies/ Top stories

GSK signs $300m R&D deal with 23andMe

Piotr Wnuk dna, genetic testing, GlaxoSmithKline 0 Comment

GlaxoSmithKline signed a $300 million research and development deal with mail gene profiling company 23andMe, gaining access to

GSK signs $300m R&D deal with 23andMe

https://pharmaphorum.com/r-d/gsk-welcomes-23andmes-dna-database/

Insights/ Sales and Marketing/ Views & Analysis/ Views and analysis

J&J tops the pharma market cap charts – but for how long?

Piotr Wnuk AbbVie, Amazon, Google, Johnson and Johnson, Merck KGaA, Roche, Takeda, top pharma companies, top pharmaceutical companies 0 Comment

Data and analytics firm GlobalData has tracked the market cap and performance of the top 25 pharma companies

J&J tops the pharma market cap charts – but for how long?

https://pharmaphorum.com/views-and-analysis/jj-tops-pharma-market-cap-charts-long/

News/ Sales and Marketing/ US

New drugs boost Eli Lilly, ahead of animal health IPO

Piotr Wnuk Cyramza, Eli Lilly 0 Comment

Eli Lilly closed the second quarter with substantial revenue increase thanks to a strong performance from a group

New drugs boost Eli Lilly, ahead of animal health IPO

https://pharmaphorum.com/news/lilly-charges-revenue-increase/

News/ News/ Patients

HPV vaccination extended to thousands of boys in England

Piotr Wnuk HPV, HPV vaccination 0 Comment

The UK government announced the extension of HPV vaccine programme to boys in a bid protect against several

HPV vaccination extended to thousands of boys in England

https://pharmaphorum.com/news/hpv-vaccination-extended-boys-england/

News/ News/ R&D

All eyes on Biogen and Eisai’s potential Alzheimer’s breakthrough

Piotr Wnuk 0 Comment

Biogen and Eisai are working together on an Alzheimer’s disease treatment, and despite a chequered history, are hoping

All eyes on Biogen and Eisai’s potential Alzheimer’s breakthrough

https://pharmaphorum.com/news/eyes-biogen-eisai/

Market Access/ Patients/ Views & Analysis/ Views & Analysis/ Views and analysis

Live Well: when health and opportunity knocks

Piotr Wnuk CARE International, GlaxoSmithKline, Live Well 0 Comment

Live Well brings health products to the doorsteps of rural Zambians in an innovative partnership between GSK and

Live Well: when health and opportunity knocks

https://pharmaphorum.com/views-analysis-market-access/live-well-health-and-opportunity-knocks/

Trending

About Piotr Wnuk

Posts by Piotr Wnuk:

Bayer hits back at Netflix medical device documentary

EU regulators reject new use for Opdivo, as Keytruda edges ahead

Merck & Co’s Keytruda shows potential in head and neck cancer use

GSK signs $300m R&D deal with 23andMe

J&J tops the pharma market cap charts – but for how long?

New drugs boost Eli Lilly, ahead of animal health IPO

HPV vaccination extended to thousands of boys in England

All eyes on Biogen and Eisai’s potential Alzheimer’s breakthrough

Live Well: when health and opportunity knocks

Trending

About Piotr Wnuk

Posts by Piotr Wnuk:

Login